BR9507371A - Derivado de benzamida composições contendo o dito derivado e uso do mesmo - Google Patents

Derivado de benzamida composições contendo o dito derivado e uso do mesmo

Info

Publication number: BR9507371A
Authority: BR; Brazil
Prior art keywords: derivative; compositions containing; benzamide; benzamide derivative; derivative compositions
Prior art date: 1994-04-13

Application number

BR9507371A

Other languages

English (en)

Inventor

Jean-Francois Rossignol

Original Assignee

Rossignol Jean Francois

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-13

Filing date

1995-04-11

Publication date

1997-09-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27397680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9507371(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-04-13 Priority claimed from US08/227,033 external-priority patent/US5387598A/en

1994-09-08 Priority claimed from US08/301,407 external-priority patent/US5578621A/en

1995-04-11 Application filed by Rossignol Jean Francois filed Critical Rossignol Jean Francois

1997-09-23 Publication of BR9507371A publication Critical patent/BR9507371A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/58—Nitro radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BR9507371A 1994-04-13 1995-04-11 Derivado de benzamida composições contendo o dito derivado e uso do mesmo BR9507371A (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US08/227,033 US5387598A (en)	1994-04-13	1994-04-13	Composition and galenic formulation suitable for combatting affections of the lower abdomen
US08/301,407 US5578621A (en)	1994-09-08	1994-09-08	Benzamide derivatives
US38385595A	1995-02-06	1995-02-06
PCT/EP1995/001334 WO1995028393A1 (en)	1994-04-13	1995-04-11	Benzamide derivative, compositions containing said derivative and use thereof

Publications (1)

Publication Number	Publication Date
BR9507371A true BR9507371A (pt)	1997-09-23

Family

ID=27397680

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9507371A BR9507371A (pt)	1994-04-13	1995-04-11	Derivado de benzamida composições contendo o dito derivado e uso do mesmo

Country Status (24)

Country	Link
EP (1)	EP0755386B1 (pt)
JP (1)	JP3224395B2 (pt)
KR (2)	KR100373081B1 (pt)
CN (1)	CN1072654C (pt)
AP (1)	AP645A (pt)
AT (1)	ATE218557T1 (pt)
AU (1)	AU689582B2 (pt)
BG (1)	BG62932B1 (pt)
BR (1)	BR9507371A (pt)
CA (1)	CA2187110C (pt)
CZ (1)	CZ287002B6 (pt)
DE (1)	DE69526936T2 (pt)
DK (1)	DK0755386T3 (pt)
ES (1)	ES2161201T3 (pt)
FI (1)	FI120258B (pt)
HU (1)	HUT77404A (pt)
NZ (1)	NZ284800A (pt)
OA (1)	OA10463A (pt)
PL (1)	PL186504B1 (pt)
PT (1)	PT755386E (pt)
RU (1)	RU2140915C1 (pt)
SI (1)	SI0755386T1 (pt)
SK (1)	SK281949B6 (pt)
WO (1)	WO1995028393A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5856348A (en) *	1994-09-08	1999-01-05	Romark Laboratories, L.C.	Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US5968961A (en)	1997-05-07	1999-10-19	Romark Laboratories, L.C.	Pharmaceutical compositions of tizoxanide and nitazoxanide
CA2467321A1 (en)	2004-05-14	2005-11-14	Paul J. Santerre	Polymeric coupling agents and pharmaceutically-active polymers made therefrom
DE602005023181D1 (de)	2004-07-21	2010-10-07	Dana Farber Cancer Inst Inc	Lentivirusvektoren und deren verwendung
UA90864C2 (en)	2004-09-09	2010-06-10	Ромарк Лебораториз, Л.К.	Halogenated benzamide derivatives
EA015560B1 (ru)	2006-01-09	2011-08-30	Ромарк Лэборетериз, Эл.Си.	Способ лечения вирусного гепатита
WO2009035788A1 (en)	2007-08-03	2009-03-19	Romark Laboratories L.C.	Alkylsulfonyl-substituted thiazolide compounds
CA2940954A1 (en)	2009-05-12	2010-11-18	Romark Laboratories L.C.	Nitazoxanide and tizoxanide for the treatment of rhinovirus and rhabdovirus infections
MX341877B (es)	2009-06-26	2016-09-06	Romark Laboratories L C *	Compuestos y métodos para tratar influenza.
AU2010310892B2 (en)	2009-10-22	2015-07-02	Thomas Julius Borody	Novel parasite therapy
CN104094927B (zh) *	2013-04-02	2016-06-01	兴邦（武汉）生物科技有限公司	一种处理植物的助剂组合物
TW201630606A (zh) *	2015-01-21	2016-09-01	諾華公司	包含局部藥物之蓋崙（ｇａｌｅｎｉｃ）調配物
US20210113457A1 (en)	2018-02-02	2021-04-22	Ripple Therapeutics Corporation	Glass formulations and uses thereof
WO2020154815A1 (en)	2019-02-01	2020-08-06	Ripple Therapeutics Corporation	Crystalline forms of dexamethasone dimers and uses thereof
EP4010347A4 (en)	2019-08-07	2023-09-20	Ripple Therapeutics Corporation	COMPOSITIONS AND METHODS FOR TREATING PAIN AND ADDICTION DISORDERS
MX2022013665A (es)	2020-05-01	2022-11-30	Ripple Therapeutics Corp	Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.
CA3219500A1 (en) *	2021-05-28	2022-12-01	Theodore HENDERSON	Treatment using an antiviral compound and nitazoxanide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1306603A (fr) *	1958-08-14	1962-10-19	Innothera Lab Sa	Dérivés thiazoliques et leur procédé de préparation
FR716M (pt) *	1960-08-05	1961-08-07
GB1437800A (en) *	1973-08-08	1976-06-03	Phavic Sprl	Derivatives of 2-benzamido-5-nitro-thiazoles
GB1440212A (en) *	1973-08-29	1976-06-23	Phavic Sprl	Derivatives of 2-phenoxyacetamido-5-nitrothiazoles
FR2435905A1 (fr) *	1978-09-13	1980-04-11	Anvar	Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole
US4315018A (en) *	1978-12-07	1982-02-09	Rossignol Jean F	Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US4447414A (en) *	1982-12-21	1984-05-08	Cutter Laboratories, Inc.	Carnivore anthelmintics
US5387598A (en) *	1994-04-13	1995-02-07	Rossignol; Jean-Francois	Composition and galenic formulation suitable for combatting affections of the lower abdomen

1995
- 1995-04-11 DE DE69526936T patent/DE69526936T2/de not_active Revoked
- 1995-04-11 HU HU9602798A patent/HUT77404A/hu unknown
- 1995-04-11 DK DK95917310T patent/DK0755386T3/da active
- 1995-04-11 RU RU96119364A patent/RU2140915C1/ru not_active IP Right Cessation
- 1995-04-11 KR KR10-2000-7003874A patent/KR100373081B1/ko not_active Expired - Lifetime
- 1995-04-11 PL PL95316757A patent/PL186504B1/pl not_active IP Right Cessation
- 1995-04-11 BR BR9507371A patent/BR9507371A/pt not_active IP Right Cessation
- 1995-04-11 AU AU23440/95A patent/AU689582B2/en not_active Ceased
- 1995-04-11 AP APAP/P/1996/000866A patent/AP645A/en active
- 1995-04-11 NZ NZ284800A patent/NZ284800A/en not_active IP Right Cessation
- 1995-04-11 AT AT95917310T patent/ATE218557T1/de not_active IP Right Cessation
- 1995-04-11 KR KR1019960705785A patent/KR100348440B1/ko not_active Expired - Lifetime
- 1995-04-11 CZ CZ19962959A patent/CZ287002B6/cs not_active IP Right Cessation
- 1995-04-11 CN CN95192524A patent/CN1072654C/zh not_active Expired - Fee Related
- 1995-04-11 SK SK1307-96A patent/SK281949B6/sk not_active IP Right Cessation
- 1995-04-11 EP EP95917310A patent/EP0755386B1/en not_active Revoked
- 1995-04-11 SI SI9530607T patent/SI0755386T1/xx unknown
- 1995-04-11 WO PCT/EP1995/001334 patent/WO1995028393A1/en not_active Ceased
- 1995-04-11 ES ES95917310T patent/ES2161201T3/es not_active Expired - Lifetime
- 1995-04-11 JP JP52669395A patent/JP3224395B2/ja not_active Expired - Lifetime
- 1995-04-11 CA CA002187110A patent/CA2187110C/en not_active Expired - Lifetime
- 1995-04-11 PT PT95917310T patent/PT755386E/pt unknown
1996
- 1996-10-03 BG BG100884A patent/BG62932B1/bg unknown
- 1996-10-04 OA OA60900A patent/OA10463A/en unknown
- 1996-10-08 FI FI964031A patent/FI120258B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
SK130796A3 (en)	1997-06-04
FI964031L (fi)	1996-10-08
JP3224395B2 (ja)	2001-10-29
AU2344095A (en)	1995-11-10
CA2187110C (en)	2002-03-19
SI0755386T1 (en)	2002-10-31
DK0755386T3 (da)	2002-08-26
BG100884A (en)	1997-07-31
CN1145621A (zh)	1997-03-19
DE69526936T2 (de)	2003-02-20
PT755386E (pt)	2002-11-29
BG62932B1 (bg)	2000-11-30
PL186504B1 (pl)	2004-01-30
JPH09511997A (ja)	1997-12-02
ATE218557T1 (de)	2002-06-15
KR100348440B1 (ko)	2002-11-29
CA2187110A1 (en)	1995-10-26
KR100373081B1 (ko)	2003-02-25
CN1072654C (zh)	2001-10-10
FI964031A0 (fi)	1996-10-08
DE69526936D1 (de)	2002-07-11
ES2161201T1 (es)	2001-12-01
WO1995028393A1 (en)	1995-10-26
OA10463A (en)	2002-04-03
EP0755386B1 (en)	2002-06-05
NZ284800A (en)	1998-02-26
RU2140915C1 (ru)	1999-11-10
CZ295996A3 (en)	1997-03-12
PL316757A1 (en)	1997-02-03
FI120258B (fi)	2009-08-31
HUT77404A (hu)	1998-04-28
ES2161201T3 (es)	2002-12-01
CZ287002B6 (en)	2000-08-16
HU9602798D0 (en)	1996-12-30
AP645A (en)	1998-04-24
AP9600866A0 (en)	1996-10-31
SK281949B6 (sk)	2001-09-11
EP0755386A1 (en)	1997-01-29
AU689582B2 (en)	1998-04-02

Publication	Publication Date	Title
FI955051L (fi)	1996-04-25	Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
DE69526966D1 (de)	2002-07-11	Hautkräftigende kometische zusammensetzung
NO954201L (no)	1996-04-26	Kosmetikk-blanding
FI941747L (fi)	1994-04-15	Koostumuksia ja niiden käyttöjä
FI964334L (fi)	1996-11-01	Polymeroitava koostumus ja sen käyttö
BR9509200A (pt)	1997-12-30	Composição de matéria
BR9707501A (pt)	1999-07-27	Composto composição farmacêutica e uso do composto
DE69516019D1 (de)	2000-05-04	Verdikte persäurezusammensetzungen
FI954773A7 (fi)	1996-04-08	Antihypertriglyserideeminen koostumus
BR9507371A (pt)	1997-09-23	Derivado de benzamida composições contendo o dito derivado e uso do mesmo
CY2010001I1 (el)	2010-07-28	Εντεροκινητικο βενζαμιδιο
BR9711191A (pt)	1999-08-17	Composto e uso do mesmo
FI972245A0 (fi)	1997-05-28	Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
BR9506583A (pt)	1997-09-23	Composição cosmética e uso da mesma
BR9707808A (pt)	1999-07-27	Composto composição farmacêutica e uso do composto
KR970703779A (ko)	1997-08-09	건강 조성물(health composition)
DE69503941D1 (de)	1998-09-17	Klebstoffzusammensetzung
BR9612413A (pt)	1999-07-13	Composto uso do mesmo e composição farmacêutica
ITMI940362A0 (it)	1994-03-01	Composizione antitosse
BR7401412U (pt)	1996-06-04	Estojo de uso pessoal
MA23731A1 (fr)	1996-07-01	Compositions detegentes
FI963130A7 (fi)	1996-10-09	Heterosykliset yhdisteet sekä niiden valmistus ja käyttö
FI965097L (fi)	1996-12-18	Substituoidut alkyylidiamiinijohdannaiset ja niiden käyttö takykiniini antagonisteina
BR9509055A (pt)	1998-06-23	Imidazoloquinoxalinona uso da mesma e composiçao farmacêutica
NO972216D0 (no)	1997-05-14	Acrotein-frigjörende sammensetning og dens anvendelse

Legal Events

Date	Code	Title	Description
2001-07-17	EG	Technical examination (opinion): publication of technical examination (opinion)
2002-05-28	FB36	Technical and formal requirements: requirement - article 36 of industrial property law
2002-09-24	HJEG	Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
2003-03-25	FF	Decision: intention to grant
2003-09-23	PC	Transfer	Owner name: ROMARK LABORATORIES L.C. (US)
2003-11-11	FG9A	Patent or certificate of addition granted
2015-11-03	B21A	Patent or certificate of addition expired [chapter 21.1 patent gazette]	Free format text: PATENTE EXTINTA EM 11/04/2015